Marina Biotech, Inc. Announces That Licensee Mirna Therapeutics, Inc. Reported Initiation of a Phase 1 Clinical Trial of Anticancer Drug MRX34
5/13/2013 11:48:23 AM
More...
|
Marina Biotech, Inc. Announces Year-to-Date 2012 Financial Results
12/6/2012 10:11:32 AM
More...
|
Marina Biotech, Inc. Announces That Licensee ProNAi Therapeutics, Inc. Reported Phase 1 Study Results Using SMARTICLES® Nucleic Acid Delivery Technology
12/5/2012 9:42:39 AM
More...
|
Marina Biotech, Inc. Receives Key Patent Issuance From the USPTO for Its Unlocked Nucleobase Analog (UNA) Chemistry
12/4/2012 10:22:31 AM
More...
|
Tekmira Pharmaceuticals Corporation and Marina Biotech, Inc. Sign RNA Tech Deal
11/29/2012 7:06:30 AM
More...
|
Marina Biotech, Inc. Announces Full Year 2011 Financial Results
10/11/2012 9:05:34 AM
More...
|
Marina Biotech, Inc. Provides Update on Company Operations
8/22/2012 9:14:31 AM
More...
|
Marina Biotech, Inc. Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry
8/3/2012 10:06:04 AM
More...
|
Marina Biotech, Inc. Lays Off 90% of Staff, Ceases Most Daily Operations
6/1/2012 8:19:10 AM
More...
|
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) and Girindus Announce Strategic Alliance
5/21/2012 8:02:18 AM
More...
|
|